Comparison 5.

Adverse events for all included trials

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Adverse events during the treatment phase	23	1472	Risk Difference (M‐H, Random, 95% CI)	0.02 [‐0.01, 0.05]